Search Results 141-150 of 14954 for infliximab

  1. Medication Therapy Management to Optimize Care Through Effective Resource Management in Inflammatory Bowel Disease - Mayo Clinic

    About this study. The management of Inflammatory Bowel Disease (IBD) is complex and time consuming. While Current Procedural Terminology for MTM services ...

  2. A Study of Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Adult and Adolescent Subjects With Active Crohn's Disease - Mayo Clinic

    ... infliximab, adalimumab, certolizumab, or vedolizumab). Exclusion Criteria: • The presence of any of the following will exclude a subject from enrollment ...

  3. Crohn's disease - Doctors and departments - Mayo Clinic

    Radiologists at Mayo Clinic were instrumental in developing novel bowel imaging techniques, including magnetic resonance (MR) and CT enterography. Current ...

  4. Mayo Clinic

    ... . VID-20464900. Home; Mayo Clinic Treatment Center. 5X Challenge is here! 5X My Gift! Your gift today can have 5X the impact on AI research and ...

  5. Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis - Mayo Clinic

    8 week washout for infliximab or adalimumab; 2 week washout for etanercept; 1 week washout for anakinra. If an IS agent is continued, the dose must remain ...

  6. Rituximab Vasculitis Maintenance Study - Mayo Clinic

    IVIg, infliximab, etanercept, adalimumab, abatacept or plasma exchange in past 3 months; Any investigational agent within 28 days of screening, or 5 half ...

  7. A Study to Evaluate the Effectiveness and Safety of Risankizumab in Subjects with Moderately-to-Severely Active Ulcerative Colitis - Mayo Clinic

    At least one 6-week induction regimen of infliximab (≥ 5 mg/kg intravenous [IV] ... approved biologic agent (e.g., infliximab, adalimumab, golimumab ...

  8. Mayo Clinic

    ... . VID-20558494. Home; Facial reanimation surgery - playlist. 5X Challenge is here! 5X My Gift! Your gift today can have 5X the impact on AI research and ...

  9. Impact of Surgical Removal or Reduction Procedures on Markers of Immune Function in Adult Patients with Renal and Bladder Tumors and Pediatric Patients with Genitourinary Tumors - Mayo Clinic

    infliximab), chemotherapy) or imunosuppressive condition (ex. transplant, immunodeficiency syndromes, HIV/AIDS); Auto-immune disease (ex. lupus, rheumatoid ...

  10. Inflammatory bowel disease (IBD) - Doctors and departments - Mayo Clinic

    Long-lasting diarrhea and belly pain could be caused by inflammatory bowel disease, also called IBD. Learn about IBD causes, diagnosis and treatment.